Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Lipovac, V. | Gavella, M. | Coce, F.
Affiliations: Vuk Vrhovac Institute for Diabetes, Endocrinology and Metabolic Diseases, Faculty of Medicine, University of Zagreb, Dugi dol 4a, 41000 Zagreb, Yugoslavia
Note: [] Accepted by: Editor M.R. Boisseau
Abstract: A double-blind trial was conducted among 41 diabetics with peripheral occlusive angiopathy to evaluate the effectiveness of Chinoin on blood rheology abnormalities. A significant improvement in whole blood filterability was obtained in a hypercholesterolaemic subgroup of these patients following 6 months of Chinoin treatment. These changes were probably due to the drug induced reduction in serum cholesterol and protein levels. The leucocyte counts in this subgroup did not undergo significant changes. The results obtained indicate that Chinoin may at least in part reduce blood rheology abnormalities in vasculopathy of diabetics.
Keywords: Diabetes, Erythrocyte filterability, Chinoin, Occlusive angiopathy
DOI: 10.3233/CH-1989-9607
Journal: Clinical Hemorheology and Microcirculation, vol. 9, no. 6, pp. 965-972, 1989
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl